8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2020 / Multicenter, randomized, double-blind, placebo-controlled trial
One hundred menopausal Korean women were randomly assigned to receive either 400 mg/day of porcine placental extract (PPE) or a placebo for 12 weeks. While the Kupperman Index (KMI) decreased in both groups, the overall difference between groups was not statistically significant. However, KMI decreased significantly more with PPE than placebo in women with BMI 23 kg/m2 or higher (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05) and in early menopausal women (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). Estradiol levels also increased significantly in the PPE group at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05).
Lee JY, Lee C, Yoon SH, et al. Taiwan J Obstet Gynecol, 2020. PMID 32917317
2020 / Randomized, placebo-controlled study
Participants were randomized to wear a novel nasal device for 5-12 hours daily or receive daily saline nasal drops, alongside a 500 kcal/day reduced diet for 12 weeks. Sense of smell decreased from 6.4 ± 0.9 to 4.4 ± 1.5 in the device group (p < 0.001) with no change in controls. Overall weight loss was 6.6 ± 3.7% in the device group versus 5.7 ± 3.5% in controls (between-group p > 0.05), but was significantly greater with the device among participants aged ≤50 years (7.7 ± 4.2% vs. 4.1 ± 2.9%, p = 0.02). The device group also showed significant reductions in insulin, HOMA-IR, and preferences for sugar, sweet beverages, and artificial sweeteners.
Dicker D, Beck A, Markel A, et al. Obes Facts, 2020. PMID 32950989
2019 / Three experimental studies (laboratory and field)
Three studies examined the effect of a justification cue (license condition) versus no cue (control condition) on caloric consumption. In Studies 1 (N = 85) and 2 (N = 95), participants could eat freely from unhealthy snacks, while in Study 3 (N = 110), participants chose a snack at a take-out lunch place. Across all studies, caloric consumption was higher in the license condition compared to the control condition, with participants eating more unhealthy snacks in Studies 1 and 2 and choosing higher-calorie snacks in Study 3.
Prinsen S, Evers C, de Ridder DTD Psychol Health, 2019. PMID 30422003
2019 / Three-group randomized crossover trial
Researchers evaluated the acute effects of two energy- and macronutrient-matched meals—a vegan meal with tofu (V-meal) versus a processed-meat and cheese meal (M-meal)—in men with type 2 diabetes, obese men, and healthy men (n=20 each). Postprandial GLP-1 secretion increased after the V-meal in diabetic men (by 30.5%) and healthy men (by 15.8%), while amylin increased across all groups (diabetic by 15.7%, obese by 11.5%, healthy by 13.8%). Postprandial PYY increased significantly only in healthy men (by 18.9%). Satiety was higher after the V-meal in all groups: by 9% in diabetic, 18.7% in obese, and 25% in healthy men.
Klementova M, Thieme L, Haluzik M, et al. Nutrients, 2019. PMID 30642053
2019 / Single-blinded randomized controlled trial
In a 12-week single-blinded trial, 77 constipated patients with type 2 diabetes received cookies containing 10 g flaxseed, 10 g psyllium, or placebo twice daily. Compared to placebo, both flaxseed and psyllium groups showed significant improvements from baseline in constipation symptoms (P = 0.002), stool consistency (P < 0.001), weight (P < 0.001), BMI (P < 0.001), fasting plasma glucose (P = 0.004), cholesterol (P = 0.010), LDL cholesterol (P = 0.031), and cholesterol/HDL cholesterol ratio (P = 0.019). Flaxseed appeared superior to psyllium for improving these markers, and no adverse effects were observed.
Soltanian N, Janghorbani M Clin Nutr ESPEN, 2019. PMID 30661699
2019 / Randomized controlled crossover trial
Twenty-four overweight men completed a randomized crossover trial evaluating extruded sorghum versus extruded wheat during two 8-week periods with a 4-week washout. Sorghum intake reduced body fat percentage and raised daily intakes of carbohydrate and dietary fiber compared with wheat. Serum glutathione peroxidase concentration increased with sorghum, but this change did not differ significantly from wheat.
Anunciação PC, Cardoso LM, Alfenas RCG, et al. Food Res Int, 2019. PMID 30884705
2019 / Cluster randomized controlled trial
A cluster randomized trial evaluated an 8-module workplace wellness program led by dietitians across 160 worksites (20 intervention sites with 4,037 employees and 140 control sites with 28,937 employees). After 18 months, intervention participants reported higher rates of engaging in regular exercise (69.8% vs 61.9%; adjusted difference, 8.3 percentage points) and actively managing weight (69.2% vs 54.7%; adjusted difference, 13.6 percentage points). However, there were no significant effects on 27 other self-reported outcomes (including food choices), 10 clinical markers (including cholesterol, blood pressure, and BMI), 38 health spending/utilization metrics, or 3 employment outcomes.
Song Z, Baicker K JAMA, 2019. PMID 30990549
2019 / Randomized controlled clinical trial
Fifty-five obese women without baseline selenium deficiency were randomly assigned to consume 1 unit/d of Brazil nuts (~1261 μg/Se) or no intervention for 2 months. In the Brazil nut group, all selenium biomarkers and the gene expression of proinflammatory parameters (interleukin-6, tumor necrosis factor-α, and Toll-like receptors 2 and 4) increased significantly (P < 0.05). No changes occurred in the control group. While plasma inflammatory biomarker levels did not change, the authors concluded that the increased gene expression may indicate a proinflammatory stimulus induced by high-selenium Brazil nut consumption in obesity.
Duarte GBS, Reis BZ, Rogero MM, et al. Nutrition, 2019. PMID 31026738
2019 / Inpatient randomized crossover trial
Twenty weight-stable adults were admitted to an inpatient clinical center and randomized to consume ad libitum ultra-processed or unprocessed diets for 2 weeks each in a crossover design, with meals matched for presented calories, energy density, macronutrients, sugar, sodium, and fiber. Energy intake was higher during the ultra-processed diet (508 ± 106 kcal/day; p = 0.0001), driven by increased carbohydrate (280 ± 54 kcal/day; p < 0.0001) and fat (230 ± 53 kcal/day; p = 0.0004), but not protein (-2 ± 12 kcal/day; p = 0.85). Participants gained 0.9 ± 0.3 kg (p = 0.009) during the ultra-processed diet and lost 0.9 ± 0.3 kg (p = 0.007) during the unprocessed diet.
Hall KD, Ayuketah A, Brychta R, et al. Cell Metab, 2019. PMID 31105044
2019 / 8-week randomized, double-blind, placebo-controlled clinical trial
An 8-week randomized, double-blind, placebo-controlled trial evaluated the safety and oral availability of nicotinamide riboside chloride (NIAGEN) in overweight, healthy men and women. Daily consumption of 100, 300, and 1000 mg NR dose-dependently and significantly increased whole blood NAD+ by 22%, 51%, and 142% within 2 weeks, with increases maintained for the remainder of the study. No flushing occurred, and adverse events did not differ significantly between NR and placebo groups or across doses. Additionally, NR did not elevate LDL cholesterol or dysregulate 1-carbon metabolism.
Conze D, Brenner C, Kruger CL Sci Rep, 2019. PMID 31278280
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2019 / 12-week randomized, double-blind, placebo-controlled parallel-group trial
A 12-week randomized, double-blind, placebo-controlled trial evaluated the effects of nicotinamide riboside (NR; 1000 mg twice daily, n = 20) versus placebo (n = 20) in 40 males with obesity and insulin resistance. Supplementation with NR did not affect fasting or postchallenge levels of glucose, insulin, C-peptide, glucagon, GLP-1, or GIP, and β-cell function did not respond to the intervention. Furthermore, no changes in circulating adipsin or bile acids were observed.
Dollerup OL, Trammell SAJ, Hartmann B, et al. J Clin Endocrinol Metab, 2019. PMID 31390002
2019 / Randomized, double-blind, placebo-controlled pilot study
A randomized, double-blind, placebo-controlled pilot study evaluated 60 overweight adults with symptomatic knee osteoarthritis assigned to 600 mg of non-animal chondroitin sulfate (CS) daily or placebo for 12 weeks. The experimental group showed a significant increase in Tegner Lysholm Knee Scoring (+10.64 points; 95% CI 5.57, 15.70; p < 0.01) and a decrease in WOMAC score (-12.24 points; 95% CI -16.01, -8.38; p < 0.01). Significant decreases were also seen in C-reactive protein (-0.14 mg/dL; 95% CI -0.26, -0.04; p < 0.01), erythrocyte sedimentation rate (-5.01 mm/h; 95% CI -9.18, -0.84; p < 0.01), and visual analogue scale pain scores in both knees.
Rondanelli M, Braschi V, Gasparri C, et al. Nutrients, 2019. PMID 31470599
2019 / Single-arm pre-post intervention study
Researchers evaluated an 8-week group program utilizing an ad-libitum whole-food plant-based dietary pattern in 79 self-referred participants, with 78 completing. Completers achieved an average weight loss of 5.5 ± 3.0 kg (p < 0.0001), with larger percentage losses in those with higher baseline BMI. Systolic blood pressure decreased by 7.1 ± 15.5 mmHg (p = 0.0002), diastolic blood pressure decreased by 7.3 ± 10.9 mmHg (p < 0.0001), total cholesterol decreased by 25.2 ± 24.7 mg/dL (p < 0.0001), and LDL decreased by 15.3 ± 21.1 mg/dL (p < 0.0001). Additionally, 21 participants (26.9%) decreased or stopped at least one chronic medication.
Campbell EK, Fidahusain M, Campbell Ii TM Nutrients, 2019. PMID 31484341
2019 / Prospective intervention study with a matched control group
Researchers compared 27 overweight/obese women with PCOS to 25 matched controls after a 3-day standardized diet, followed by a 3-month oral contraceptive (OC) intervention with dietary advice in the PCOS group. At baseline, the PCOS group showed significantly higher serum levels of TMAO, choline, betaine, and carnitine, with TMAO and choline correlating with total testosterone. Following the 3-month OC therapy and lifestyle intervention, TMAO and its precursors significantly decreased alongside reductions in BMI, total testosterone, and free androgen index.
Eyupoglu ND, Caliskan Guzelce E, Acikgoz A, et al. Clin Endocrinol (Oxf), 2019. PMID 31556132
2019 / Randomized controlled trial
Thirty adult men completed a 24-hour water-only fast on the same day of the week for three subsequent weeks, receiving placebo or a bitter hops-based appetite suppressant (Amarasate) at high (250 mg) or low (100 mg) doses at 16 and 20 hours into the fast. From 18 to 24 hours of the fast, both high- and low-dose groups had a statistically significant (p < 0.05) greater than 10% reduction in hunger compared with placebo. Furthermore, the expected lunchtime rise in hunger seen at 12:00 h in the placebo group was absent in both hops extract treatment groups.
Walker E, Lo K, Tham S, et al. Nutrients, 2019. PMID 31766216
2019 / Randomized controlled trial
In a randomized trial, 70 healthy Japanese adults with a BMI between 23 and 30 consumed 9 grams daily of either quercetin-rich onion powder or placebo for 12 weeks. Visceral fat area did not differ significantly between the groups overall, though it was lower with onion powder in participants with low HDL cholesterol. Alanine aminotransferase levels were also significantly reduced in the onion powder arm compared to placebo.
Nishimura M, Muro T, Kobori M, et al. Nutrients, 2019. PMID 31905615
2018 / Randomized controlled pilot trial
Twenty-four obese male veterans were randomized to either a 5:2 intermittent energy-restricted diet or a standard daily energy-restricted diet for 6 months. Mean weight loss was 5.3 ± 3.0 kg (5.5 ± 3.2%) with the 5:2 diet and 5.5 ± 4.3 kg (5.4 ± 4.2%) with standard restriction, with no significant differences between groups for weight or waist reduction. Systolic blood pressure decreased in both groups, but neither regimen significantly shifted diastolic pressure, fasting glucose, or blood lipids.
Conley M, Le Fevre L, Haywood C, et al. Nutr Diet, 2018. PMID 28791787
2018 / 2-year prospective randomized trial
In a 2-year randomized trial, 70 healthy postmenopausal overweight or obese women were assigned to a Paleolithic-type diet (PD, n=35) or a diet based on Nordic Nutrition Recommendations (NNR, n=35). At baseline, median 24-h urinary iodine concentration (24-UIC, 71.0 μg/l) and excretion (24-UIE, 134.0 μg/d) were similar between groups. After 6 months, 24-UIC fell to 36.0 μg/l (P=0.001) and 24-UIE dropped to 77.0 μg/d (P=0.001) in the PD group, while levels remained unaltered in the NNR group. Free thyroxin, TSH, and free triiodothyronine (FT3) were generally similar between groups, though FT3 was lower in the PD group at 6 months.
Manousou S, Stål M, Larsson C, et al. Eur J Clin Nutr, 2018. PMID 28901333
2018 / Controlled trial
Participants (n = 51) were provided an 825-calorie lunch eaten either while listening to an audio clip prompting focus on sensory properties of food or in silence, followed by a snack offered 2 hours later. While lunch intake did not differ significantly between groups, the mindful eating group consumed significantly fewer snack calories than controls (mean = 112.30 calories, SD = 70.24 vs. mean = 203.20 calories, SD = 88.05; Cohen's d = 1.14). This effect was not explained by enhanced memory for lunch and occurred regardless of gender or interoceptive awareness, with no significant moderation by reward sensitivity.
Seguias L, Tapper K Appetite, 2018. PMID 29104106
2018 / Randomized crossover trial
Eighteen healthy volunteers completed two study visits following an overnight fast, receiving tablets containing either 6845 mg sodium propionate or 4164 mg sodium chloride over 180 minutes in random order. REE and substrate oxidation were measured by indirect calorimetry. Oral sodium propionate administration significantly increased REE (0.045 ± 0.020 kcal/min; P = .036) and whole-body lipid oxidation (0.012 ± 0.006 g/min; P = .048), independent of glucose and insulin changes.
Chambers ES, Byrne CS, Aspey K, et al. Diabetes Obes Metab, 2018. PMID 29134744
2018 / Randomized controlled trial
In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.
Most J, Gilmore LA, Smith SR, et al. Am J Physiol Endocrinol Metab, 2018. PMID 29351490
2018 / Secondary analysis of a randomized controlled trial
Thirty-four obese participants completed 12 months of alternate-day fasting and were categorized by achieving at least 5% weight loss or under 5% weight loss. The high-loss group experienced increased fullness (p = 0.04) and decreased hunger (p = 0.03). They also raised dietary protein from 15% to 20% of energy intake (p = 0.04) and adhered more closely to fast-day caloric targets.
Kroeger CM, Trepanowski JF, Klempel MC, et al. Nutr Health, 2018. PMID 29353535
2018 / Parallel-design randomized controlled trial
Forty-two normal-weight healthy short sleepers were randomized to a sleep extension group receiving a sleep hygiene behavioral consultation (n = 21) or a control group maintaining habitual short sleep (n = 21) for 4 weeks. Compared with controls, the sleep extension group significantly increased time in bed (0:55 h:mm), sleep period (0:47 h:mm), and sleep duration (0:21 h:mm). Sleep extension led to a significant reduction in free sugar intake (-9.6 g vs. 0.7 g in controls; P = 0.042), with no significant differences observed between groups in markers of energy balance or cardiometabolic health.
Al Khatib HK, Hall WL, Creedon A, et al. Am J Clin Nutr, 2018. PMID 29381788